Wayne L. Furman

Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors

L. McGregor, R. Brennan, W. Furman, 2014, Cancer Chemotherapy and Pharmacology.

Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy

W. Furman, M. B. McCarville, Jianrong Wu, 2018, International Journal of Clinical Oncology.

Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumors

Sara M. Federico, A. Davidoff, F. Navid, 2021 .

Evaluation of Gefitinib for Treatment of Refractory Solid Tumors and Central Nervous System Malignancies in Pediatric Patients

N. Daw, W. Furman, C. Stewart, 2006, Cancer investigation.

Phase I study of topotecan for pediatric patients with malignant solid tumors.

W. Furman, C. Pratt, J. Kuttesch, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: a Pediatric Oncology Group study.

W. Furman, C. Pratt, B. Leventhal, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma

P. Houghton, A. Davidoff, L. McGregor, 2012, Investigational New Drugs.

Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecan.

P. Houghton, W. Furman, C. Stewart, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors.

P. Houghton, J. Panetta, N. Daw, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.